Company profile: Pharm2Farm
1.1 - Company Overview
Company description
- Provider of products produced and sold under an exclusive licence to technology from Nottingham Trent University (NTU); a spin-out from NTU.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Pharm2Farm
Nearfield Instruments
HQ: The Netherlands
Website
- Description: Provider of advanced metrology systems for semiconductor manufacturing, creating high-throughput scanning probe solutions for atomic-scale resolution and improved process control. Offerings include QUADRA for 3D process control of high aspect-ratio structures, AUDIRA for in-line, non-destructive subsurface metrology, and the FFTP imaging mode for on-device measurements at 3nm and beyond.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nearfield Instruments company profile →
Aledia
HQ: France
Website
- Description: Provider of 3D LED and microLED display technologies, including silicon nanowire microLEDs for energy-efficient, high-resolution screens; WireLED using gallium nitride nanorods on silicon to cut cost and growth time; Nova Blue microLED for cost-effective mass production in small/mid-size displays; 3D microLEDs for smart devices and large displays; and SmartPixel for flexible, deformable, transparent HDR screens.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Aledia company profile →
Nanocyl
HQ: Belgium
Website
- Description: Provider of carbon nanotubes (CNTs) and formulated CNT products that improve ESD/electrical conductivity, mechanical reinforcement, thermal dissipation and eco-friendly fouling release. Products: NC7000 industrial multiwall CNTs; PLASTICYL CNT masterbatches in thermoplastics; AQUACYL waterborne dispersions for coatings and energy storage; ORGACYL solventborne dispersions; EPOCYL epoxy concentrates; THERMOCYL silicone-based flame retardant coatings.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nanocyl company profile →
Vorbeck Materials
HQ: United States
Website
- Description: Provider of graphene materials (Vor-x) for industrial and energy applications; ultra-flexible, robust conductive inks and coatings (Vor-ink) for printed electronics; high-performance graphene-enabled electronic components; and custom technology solutions for municipalities, states, US Special Operations Command, and front-line troops, focusing on high-bandwidth communication and situational awareness.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Vorbeck Materials company profile →
SiSaf
HQ: United Kingdom
Website
- Description: Provider of RNA delivery and therapeutics leveraging proprietary Bio-Courier, a hybrid organic–inorganic platform using bioabsorbable silicon and silicon stabilized hybrid lipid nanoparticles (sshLNP). Pipeline includes siRNA/miRNA therapies for Osteopetrosis Type II (SIS-101-ADO), Achondroplasia (SIS-102-ACH), pancreatic cancer (SIS-401-PACA), targeting genes correlating with cancer progression and mortality (SIS-402-SBC), and Type II Corneal Dystrophy (SIS-201-CD).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full SiSaf company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Pharm2Farm
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Pharm2Farm
2.2 - Growth funds investing in similar companies to Pharm2Farm
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Pharm2Farm
4.2 - Public trading comparable groups for Pharm2Farm
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →